MedTrace Logo

Evaluation of Volume Status in Peritoneal Dialysis Patients

NCT00182338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2011-07-20

No results posted yet for this study

Summary

Patients with kidney failure on dialysis have a much higher risk of developing cardiovascular disease as compared to the general population. Recently, two large studies have shown that increasing the amount of dialysis does not decrease cardiovascular disease. It is known that retaining too much fluid leads to high blood pressure and thickening of the heart wall. Peritoneal dialysis is a method of home dialysis which allows dialysis patients autonomy and independence. This study will measure blood levels of a protein called N-BNP and measure the extent of body fluid by a machine called a bioimpedance analyzer. This device administers an undetectible electric current which distributes throughout total body water. The relationship between these tests and the clinical presence of volume expansion will be assessed. In addition, the extent of total body fluid and it's impact on heart attacks, heart failure and stroke will be determined.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Scott K Brimble, MD · McMaster University

  • Peter Margetts, MD, PhD · McMaster University

  • David N Churchill, MD, MSc · McMaster University

  • Azim S Gangji, MD · McMaster University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182338 on ClinicalTrials.gov